Jayasree K. Iyer comments on GSK’s approach to IP and Patents on Access to Medicine
Jayasree K. Iyer shares her views on the announcement made by Sir Andrew Witty regarding GSK’s “graduated approach” to Intellectual Property and Patents. She also discusses the overall impact of the approach on the pharmaceutical industry.
Date
01 April 2016